tirzepatide landmark trial for masld Tirzepatide- A novel therapeutic against metabolic dysfunction-associated steatotic liver disease (MASLD) A phase 3 trial reported
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3























